Budget Impact Analysis or Pharmacological Therapy of Chronic Myeloid Leukemia (Cml) with Nilotinib as the Second-Line Treatment in Russian Federation
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1089
https://www.valueinhealthjournal.com/article/S1098-3015(15)03165-4/fulltext
Title :
Budget Impact Analysis or Pharmacological Therapy of Chronic Myeloid Leukemia (Cml) with Nilotinib as the Second-Line Treatment in Russian Federation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03165-4&doi=10.1016/j.jval.2015.09.1089
First page :
A442
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
591